A Single-Center, Open Label Pilot Study Examining The Use Of Duloxetine In The Prevention Of Episodic Migraine.

Trial Profile

A Single-Center, Open Label Pilot Study Examining The Use Of Duloxetine In The Prevention Of Episodic Migraine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2014

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Migraine with aura; Migraine without aura
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2011 Planned end date changed from 1 Mar 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 27 Oct 2010 Planned end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 27 Oct 2010 Actual initiation date (Aug 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top